Burdick Kenneth A reported option exercise involving 75,000 shares of LifeStance Health Group, Inc. at $7.61 for $571k on Nov 10, 2026

Option exercise
Form 4 code M. Exercise or conversion of a derivative security exempt under Rule 16b-3.
Director
DIR
Filed Nov 12, 2026

Facts from the filing

Form 4 · Non-derivative, table I
Disclosed value
$570,750Shares × reported price
Shares traded
75,000Common Stock
Price per share
$7.61Reported price. Read footnotes for ranges.
% of reported position traded
UnavailableThis security and ownership context
Holdings after
2,979,221Direct
Trade date
Nov 10, 2026Option exercise
Filed
Nov 12, 2026, 5:00 PM ET2-day reporting delay
Accession
0001193125-26-458675Code M · Transaction 399313
How reported position traded is calculated

Calculated only for code-P purchases and code-S sales.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

Other trades in this filing

Trade dateActivitySharesPriceValueDetails
Nov 9, 2026Sell66,589$14.41−$959,547.49Trade 399312
Nov 10, 2026Sell75,000$14.60−$1,095,000Trade 399314
Nov 10, 2026Option exercise75,000$0.00$0Trade 399315
4 transaction rows in this filing. Joint filers share the same rows.

LFST price since this filing

Daily closing prices, with the filing date and available return windows. Return methodology
LFST · Daily closing priceDaily price data is pending. The chart appears when valid daily closes are available.
Filing dateReturn windows appear as prices become available.

Return windows are pending. The first 7-day window is eligible on Nov 19, 2026. Values appear when the daily price refresh supplies a valid close for that window. Weekends, market holidays and missing prices can delay updates.

Pre-filing1mo ago −5.2%1w ago 0%1d ago 0%
Returns since7d30d90d180d1y

Footnotes in full

F1: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $14.410 to $14.440 inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. F2: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $14.60 to $14.615 inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. F3: Includes an option to purchase 3,134,846 shares of the Issuer's common stock, subject to time-based vesting (the "Time-Vesting Option"). The Time-Vesting Option vested as to 25% on each of the first four anniversaries of the vesting commencement date, September 7, 2022.